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Sustained sensitizing effects of tumor necrosis factor alpha on 
sensory nerves in lung and airways
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2Department of Biomedical Sciences, Mercer University, Macon, Georgia, USA
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Abstract
Tumor necrosis factor alpha (TNFα) plays a significant role in the pathogenesis of airway 
inflammatory diseases. Inhalation of aerosolized TNFα induced airway hyperresponsiveness 
accompanied by airway inflammation in healthy human subjects, but the underlying mechanism is 
not fully understood. We recently reported a series of studies aimed to investigate if TNFα 
elevates the sensitivity of vagal bronchopulmonary sensory nerves in a mouse model; these studies 
are summarized in this mini-review. Our results showed that intratracheal instillation of TNFα 
induced pronounced airway inflammation 24 hours later, as illustrated by infiltration of 
eosinophils and neutrophils and the release of inflammatory mediators and cytokines in the lung 
and airways. Accompanying these inflammatory reactions, the sensitivity of vagal pulmonary C-
fibers and silent rapidly adapting receptors to capsaicin, a selective agonist of transient receptor 
potential vanilloid type 1 receptor, was markedly elevated after the TNFα treatment. A distinct 
increase in the sensitivity to capsaicin induced by TNFα was also observed in isolated pulmonary 
sensory neurons, suggesting that the sensitizing effect is mediated primarily through a direct action 
of TNFα on these neurons. Furthermore, the same TNFα treatment also induced a lingering (> 
7days) cough hyperresponsiveness to inhalation challenge of NH3 in awake mice. Both the airway 
inflammation and the sensitizing effect on pulmonary sensory neurons caused by the TNFα 
treatment were abolished in the TNF-receptor double homozygous mutant mice, indicating the 
involvement of TNF-receptor activation. These findings suggest that the TNFα-induced 
hypersensitivity of vagal bronchopulmonary afferents may be responsible for, at least in part, the 
airway hyperresponsiveness caused by inhaled TNFα in healthy individuals.
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Introduction
An important role of tumor necrosis factor alpha (TNFα), a pro-inflammatory cytokine, in 
the pathogenesis of airway inflammatory diseases such as allergic asthma has been 
extensively documented [1–5]. TNFα was detected in bronchoalveolar lavage fluid, exhaled 
breath condensate and sputum of asthmatic patients during acute exacerbation or after 
antigen inhalation challenge in these patients [6,7]. TNFα is released from a variety of cell 
types in the airways, such as mast cells and macrophages, via the immunoglobulin E-
dependent mechanism [2,5,8,9]. Once released, TNFα can exert multiple effects on a 
number of effector cells and induce the inflammatory reaction in the airways. Inhalation of 
aerosolized TNFα induced bronchial hyperresponsiveness accompanied by airway 
inflammation in healthy human subjects [10], but the underlying mechanism was not fully 
understood. One of the prominent pathophysiological features of inflammation-induced 
bronchial hyperresponsiveness is a heightened sensitivity of airway sensory nerves [11,12].
Previous investigators have repeatedly reported that TNFα induced a potent sensitizing 
effect on dorsal root ganglion (DRG) and trigeminal ganglion nociceptive neurons, leading 
to the development of lingering inflammatory pain in various somatic tissues [13–16]. This 
hyperalgesic effect was mediated through an action on the TNF receptors, TNFR1 and 
TNFR2, located on the cell surface, which resulted in an increase in the sensitivity and/or 
expression of transient receptor potential vanilloid type 1 (TRPV1) receptors expressed in 
these nociceptive neurons [3]. For example, in isolated DRG neurons, pretreatment with 
TNFα for a short-duration (60 s) immediately and reversibly increased the current amplitude 
evoked by activation of TRPV1 receptors, and this rapid and transient sensitizing effect of 
TNFα was attenuated by deletion of the TNFR2 gene [17]. On the other hand, exposure of 
DRG neurons to TNFα for a longer duration (48 hours) induced a pronounced increase in 
the proportion of DRG neurones expressing TRPV1 receptor-like immunoreactivity [18]. 
Interestingly, the TNFα-induced TRPV1 expression was clearly increased in the medium- 
and large-size neurons that normally do not exhibit TRPV1 sensitivity; and this effect of 
TNFα was absent in the DRG neurons isolated from mice lacking TNFR1 [18].
The C-fiber sensory nerves are the dominant subtype of vagal afferents innervating the entire 
respiratory tract in various mammalian species including mice [19–21]. Increasing evidence 
suggests that activation of these bronchopulmonary C-fiber afferents is responsible for the 
manifestation of various symptoms in the airway inflammatory diseases [11,12]. An 
abundant expression of TRPV1 in the neuronal soma and sensory terminals is a reliable and 
prominent biomarker of these C-fiber afferents [22,23]. More importantly, recent studies 
have shown that chronic airway inflammation upregulated the sensitivity and expression of 
TRPV1 in these sensory nerves innervating the airways and lungs [24,25].
In the light of these previous findings, we recently carried out a series of studies aimed to 
investigate if airway delivery of TNFα induced airway inflammation and elevated the 
TRPV1 sensitivity of bronchopulmonary sensory nerves; and if so, whether the sensitizing 
effect of TNFα was mediated through its action on TNFRs. Mouse was chosen as the animal 
species for these studies so that the involvement of TNFRs could be evaluated in TNF-
receptor double homozygous mutant mice (TNF−/−). Experimental methods, protocols and 
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results of these studies have been reported in details in our recent publications [26–28], and 
a collected summary of this series of studies is presented in this mini-review.
Airway inflammation induced by TNFα
TNFα released from mast cells, macrophages and other inflammatory cells can trigger 
diverse and potent inflammatory responses in the airways. Activation of TNFRs by TNFα 
can cause a chemotactic action, upregulate the leukocyte-endothelial cell adhesive molecules 
E-selectin and vascular cell adhesion molecule-1, which in turn can enhance the production 
of Th2 cytokines and cause infiltration and degranulation of these inflammatory cells such as 
neutrophils and eosinophils in the airways [5,10,29,30]. These diverse actions of TNFα can 
further enhance the release of various pro-inflammatory/chemotactic mediators [5,29]. We 
carried out this study to determine whether airway inflammation is induced by TNFα 
treatment in our mouse model, and if so, if this effect is mediated through the action of 
TNFα on TNFRs. The experiments were carried out in two groups of young male mice: 
wild-type (WT; B6129SF2/J) and TNF−/− mice (129S-Tnfrsf1atm1ImxTnfrsf1btm1Imx/J) in 
which both types of TNF receptors, TNFR1 and TNFR2, were mutated.
The animal preparation and experimental methods were described in details by Lin et al 
[27]. Briefly, after mice were anesthetized by isoflurane inhalation, a small (~0.5 cm) mid-
line incision was made on the ventral neck skin to expose the trachea. Under sterile 
condition, TNFα solution (10 µg/ml; 0.03 ml) and its vehicle (Veh; phosphate buffered 
saline, 0.03 ml) were instilled into the trachea via a needle (28-gauge) in treated (TNFα) and 
control (Veh) mice, respectively; the incision was then closed. Twenty-four hours (unless 
noted otherwise) later, bronchoalveolar lavage fluid (BALF) was obtained for measurements 
of inflammatory cells and mediators from five groups of mice: 1) Naïve group (WT mice 
receiving no surgery or treatment); 2) Veh group (WT mice treated with Veh); 3) & 4): 
TNFα 1 and 7 days groups (WT mice 1 and 7 days after treatment with TNFα); and 5) 
TNF−/−+TNFα group (TNF−/−mice treated with TNFα).
BALF samples were obtained from 5 mice in each group for the differential cell count, 
except n=7 in the TNFα (7 days) group. Results showed that the total number of leukocyte 
cells was significantly higher in the WT mice 1 day after a treatment with TNFα than that in 
each of the other four groups of mice. No significant difference was found between these 
four other groups [27]. More strikingly, the percentages of eosinophils and neutrophils in the 
TNFα (1 day) group were >15 folds higher than that in naïve, Veh, TNFα (7 days), and 
TNF−/−+TNFα groups, and no significant difference was found in either eosinophils or 
neutrophils between these four other groups [27].
Several inflammatory mediators and cytokines were selected in this study for measurements 
because their possible changes after the TNFα treatment were suggested in previous reports 
[2,5,30,31]. BALF samples were collected for ELISA from separate groups of mice, and the 
results showed that the TNFα treatment significantly elevated the levels of leukotriene (LT) 
B4, LTC4/D4/E4, histamine, thromboxane B2 and interleukin 1β in the BALF of WT mice, 
compared to that in the naïve, Veh and TNF−/− groups, and there was no significant 
difference in these inflammatory mediators and cytokine between these three other groups 
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(Fig. 1). However, we did not find any significant difference in the level of PGE2 and IL-13 
in BALF among all four groups. These measurements were not made in the TNFα (7 days) 
group. The total number of mice used in these groups varied: n = 10, 15, 15 and 5 in naïve, 
Veh, TNFα, and TNF−/−+TNFα groups, respectively. Due to the minimum BALF sample 
volumes required for various ELISA tests, certain assays (e.g., LTB4 and IL-1β) were not 
performed in all 4 groups (Fig. 1). Pentraxin 3 (PTX3), a member of the pentraxin 
superfamily of proteins that are involved in acute immunological responses to tissue injury 
[32], was probably released in response to the surgical wound and needle puncture on the 
trachea during the intra-tracheal instillation of TNFα. There was no difference in the level of 
PTX3 between TNFα- and Veh-treated mice.
Some of these autacoids such as histamine, leukotrienes and thromboxanes [27] are known 
to exert potent stimulatory and/or sensitizing effects on vagal bronchopulmonary C-fiber 
afferents [11,20].
Hypersensitivity of vagal bronchopulmonary afferents to capsaicin induced 
by TNFα
To determine if the TNFα-induced inflammation can lead to the development of airway 
hypersensitivity, we studied the effect of TNFα treatment on vagal pulmonary afferents in 
young C57BL6/J mice [26]. TNFα and Veh were administered as described earlier. One to 
two days later, single-unit activities of vagal afferents were recorded from the sectioned right 
cervical vagus nerve in anesthetized, open-chest mice. Responses to both chemical 
(capsaicin) and mechanical (lung inflation and deflation) stimulations were studied in all 
three major types of vagal bronchopulmonary afferents that were identified based upon 
conventional criteria for classifications [11]: C-fibers, rapidly adapting receptors (RARs), 
and slowly adapting receptors (SARs). Action potentials generated from C-fiber endings are 
conducted in small-diameter non-myelinated afferent fibers, whereas those from RARs and 
SARs are carried in rapid-conducting large-diameter myelinated fibers. The general location 
of each receptor in the lung and airways was identified at the end of experiment.
An intravenous bolus injection of capsaicin (Cap, a selective agonist of TRPV1 [33,34]) 
triggered an abrupt (latency <1 s) and short-duration (3–5 s) of discharge in pulmonary C-
fibers accompanied by bradycardia and hypotension (e.g., Fig. 2). The pulmonary C-fiber 
responses to both low (0.5 µg/kg) and high doses (1.0 µg/kg) of Cap were significantly 
higher in TNFα-treated mice than that in Veh-treated mice (Fig. 2). Pulmonary C-fibers 
were relatively insensitive to lung inflation, and the TNFα treatment did not increase the 
responses of pulmonary C-fibers to lung inflation.
In both Veh- and TNFα-treated mice, a large percentage of the RARs exhibited distinct 
phasic baseline activity that was synchronous with either expiratory or inspiratory phase of 
respiratory cycles. The remaining RARs had no detectable or very little respiratory-related 
baseline activity (e.g., Fig. 3). These two types of RARs were categorized as phasic RARs 
and silent RARs in this study. All of the SARs tested in this study exhibited distinct phasic 
baseline activity that reached a peak during either inspiratory or expiratory phase of the 
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respiratory cycles; the latter was found only in a relatively smaller number in the mouse lung 
[26].
In Veh-treated mice, injections of Cap did not cause significant stimulatory effect on silent 
RARs (e.g., Fig. 3A). However, the responses of these silent RARs to Cap injections were 
elevated by >10 folds in TNFα-treated mice (Figs. 3B & 3C). Furthermore, the number of 
silent RARs that were activated by Cap injections, judged by the criterion that the increase 
in fiber activity was > 1.0 imp/s, was markedly higher in TNFα-treated mice: e.g., none of 
the 9 silent RARs tested were activated by the low dose of Cap (0.5 µg/kg) in the Veh group, 
whereas 6 of the 8 silent RARs were stimulated in the TNF group (Fig. 3D). In contrast, 
there was no significant difference in the responses of silent RARs to either lung inflation 
(P>0.05) or deflation (P>0.05) between Veh- and TNFα-treated mice (Figs. 3E & 3F). In 
addition, the treatment with TNFα did not cause any potentiating effect on the responses to 
the same Cap injection, lung inflation and deflation in phasic RARs or SARs [26].
It is well recognized that the afferent activity generated by these C-fiber endings plays an 
important role in eliciting the pulmonary defense reflexes in both healthy and disease 
conditions [11,20]. Activation of these afferent endings by either inhaled chemical irritants 
or endogenous inflammatory mediators can generate respiratory sensations such as airway 
irritation and urge to cough [11]. In addition, it elicits powerful reflex responses including 
airway smooth muscle contraction, bronchial vasodilation and mucous hypersecretion 
mediated through the cholinergic reflex pathways [20,35]. Intense and/or sustained 
stimulation of these afferents causes “neurogenic inflammation” in the tracheobronchial tree: 
extravasation of macromolecules and inflammatory cell chemotaxis, which involves the 
local "axonal reflex” and release of several potent bioactive tachykinins from these sensory 
endings [36,37]. Thus, it seems logic to postulate that when the excitability of C-fiber 
afferents is enhanced by endogenous TNFα, these airway reflex responses to a given 
stimulus will be intensified.
After the TNFα treatment, a distinct sensitivity to Cap injection emerged in the silent RARs. 
This is an interesting finding because these receptors rarely exhibited any Cap sensitivity in 
control mice. However, very little information is available regarding the electrophysiological 
properties (e.g., conduction velocity, ion channels, etc.) and reflex functions of these silent 
RARs in mice. The firing behavior of these silent RARs exhibited certain features 
resembling the “high-threshold Aδ vagal afferents” described by Yu and coworkers [38]; for 
example, they displayed a very mild sensitivity to Cap and other chemical stimulants of C-
fibers (e.g., sulfur dioxide; data not shown). Based upon our observations in a follow-up 
cough study (described later), it is also possible that some of these RARs are the cough 
receptors that have been identified in other species [39,40].
Hypersensitivity of isolated pulmonary sensory neurons induced by TNFα
Because of the diverse actions of TNFα on a number of other target cells in the airways such 
as neutrophils, eosinophils and endothelial cells [5], it was impossible to determine if the 
sensitizing effect is mediated through a direct action of TNFα on these neurons in a whole-
animal preparation. Therefore, this in-vitro study was carried out to determine the direct 
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effect of TNFα in isolated mouse pulmonary sensory neurons [26], using the Ca2+ imaging 
technique [41].
Pulmonary sensory neurons were isolated and cultured from the jugular-nodose ganglia 
complex in mice [21], and identified by retrograde labeling with DiI, a fluorescent dye, as 
previously described [42]. The changes in the intracellular Ca2+ concentration, [Ca2+]i, in 
response to three concentrations of Cap (30, 100 and 300 nM) were measured in these 
neurons by the ratiometric method as described in our previous report [43].
Two matching dishes of pulmonary jugular-nodose ganglia neurons isolated and cultured 
from the same mouse were incubated with vehicle (Veh group) and 50 ng/ml of TNFα (TNF 
group) in culture medium for 24 h. In the WT neurons incubated with TNFα, Cap challenge 
evoked a rapid and transient increase in the [Ca2+]i in a concentration-dependent manner; 
this Cap-evoked increase in Ca2+]i was significantly greater than that incubated with Veh, 
particularly at the higher concentrations of Cap (100 nM & 300 nM; Fig. 4). In another 
study series, the Cap-evoked response was markedly attenuated in the TNF−/− neurons when 
the responses of [Ca2+]i to increasing concentrations of Cap were compared between 
pulmonary sensory neurons isolated from WT mice and TNF−/− mice after both groups of 
neurons were incubated with TNFα (50 ng/ml) for ~24 h. These results suggest the 
involvement of TNFR receptors in the TNFα-induced hypersensitivity of these neurons.
In an immunohistochemical study, we have previously demonstrated the presence of both 
TNFR1 and TNFR2 on the cell membrane of rat vagal pulmonary sensory neurons [44]. 
Activation of these TNFRs by TNFα can trigger several signaling pathways that are 
involved in a wide range of immunological responses and inflammatory reactions [45–47]. 
TNFα is initially produced as a membrane-anchored precursor protein, and subsequently 
cleaved into free proteins, which form biologically active homotrimers and interact with 
these TNFRs. Activation of TNFR1 is known to activate nuclear factor-kappa B [48] and 
mitogen activated protein kinases (MAPK) pathways, including the extracellular signal 
regulated kinase (ERK) [49]. Indeed, activation of p38 MAPK pathway increased TRPV1 
expression in peripheral nociceptor neurons in a transcription- independent manner [50]. 
Furthermore, it has been shown that incubation of DRG neurons with TNFα for 24-48 h 
significantly increased the proportion of DRG neurons expressing TRPV1 receptor-like 
immunoreactivity via TNFR1 and the ERK activation [18]. Interestingly, a recent study has 
demonstrated the co-localization of TNFR1 and TRPV1 in the same DRG neurons in rats 
[16].
Intracellular Ca2+ is an important signal transduction molecule and plays a significant role in 
the regulation of neuronal membrane excitability, synaptic activity and neurotransmitter 
release [51,52]. Transient changes in [Ca2+]i are known to contribute to short- or long-term 
alterations in ion channels and gene expression, and can modulate the overall function of 
these afferents [53,54]. Because Ca2+ is one of the main ion species that is conducted 
through TRPV1, the TNFα-induced increase in Ca2+ transient in response to Cap may result 
from an increase in the TRPV1 expression and/or excitability. On the other hand, the TNFα-
induced sensitization of vagal C-fiber neurons should lead to a greater degree of 
subthreshold depolarization of the neuronal membrane and/or a larger number of action 
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potentials in response to a given level of chemical stimulation, which may in turn generate a 
higher level of Ca2+ influx via voltage-dependent Ca2+ channels [26].
Cough hyperresponsiveness induced by TNFα in awake mice
One of the most important functions of these vagal bronchopulmonary afferents is to protect 
the lung and the rest of body against inhaled irritants and harmful gases in the environmental 
air. When the bronchopulmonary C-fibers are activated by irritant gases inhaled into the 
respiratory tract, it can trigger vigorous airway reflex responses such as cough, 
bronchoconstriction and airway secretion; these reflex responses can expel and/or reduce the 
penetration of these harmful gases into deeper regions of the lung. Furthermore, a subset of 
RARs have been identified and characterized as cough receptors in other species by previous 
investigators; these receptors are located in the extrapulmonary airways and quiescent during 
eupneic breathing [39,40]. Based upon these background information, we hypothesized that 
the hypersensitivity of these afferents induced by TNFα elevated the cough responses to 
inhaled irritant gases in mice. We chose ammonia (NH3) as the irritant gas to test this 
hypothesis because NH3 is generated by nature as part of the nitrogen cycle in the 
environment, and is produced in large quantity for industrial use (e.g., agriculture fertilizers 
and household cleaning products); NH3 at high concentrations (e.g., during occupational 
exposure or chemical accident) can cause lung injury and other detrimental health effects 
[55].
TNFα and Veh were administered by i.t. instillation in two separate groups of young 
C57BL6/J mice as described earlier [27], and cough responses to NH3 inhalation challenges 
were measured on days 2, 3, 6 and 7 after the TNFα or Veh treatment. Because the cough 
reflex is suppressed by general anesthesia, this study was carried out in awake mice. The 
methodology was described in details in a recent report [28]. Briefly, during the experiment, 
mice moved freely in a plexiglass recording chamber (volume 160 ml). To prevent CO2 
accumulation and hyperthermia, room air was drawn through the chamber at a constant flow 
rate (200 ml/min) by a negative pressure. The pressure change in the chamber (Pcham), audio 
and video signals of the mouse movements were recorded simultaneously and used 
collectively for analyzing the cough frequency (Fig. 5A). Because breathing is inherently 
unstable in awake free-moving mice, the accuracy of the cough analysis was further verified 
by comparing with the changes of the intra-pleural pressure (Pip) (e.g., Fig. 5A), which was 
measured directly by surgically implanting the tip of a telemetry sensor in the intra-pleural 
space [28].
The action of cough recorded in these mice consisted three distinct but tightly connected 
phases as characterized by the synchronized changes in both Pcham and Pip: it was initiated 
by an inspiratory effort followed by a chest compression, and then a forced expiration that 
coincided with a weak but detectable cough sound. Expiratory reflex, similar to that 
described in other species [56,57], were also frequently found in awake mice; in comparison, 
the expiration reflex consisted only a chest compression, with no clear or significant 
preceding inspiratory effort, and followed by a forced expiration (Fig. 5B). In addition, 
~15% of the responses could not be easily distinguished between cough and expiration 
reflexes in our experiments [28]. Because both coughs and expiration reflexes are airway 
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defense responses, they were pooled for data analysis in the evaluation of the overall cough 
responses in this study (Fig. 6).
In this study, the mouse was placed in the recording chamber for >30 min of adaptation 
period before each experiment. During the irritant gas inhalation challenge, ammonia (NH3; 
0.1% in air) was drawn into the chamber at the same flow rate as during baseline for 8 
minutes; the cough frequency was analyzed for the 5-min baseline, 8-min challenge and 5-
min recovery in each animal. The cough frequency was near zero at the baseline (before the 
NH3 inhalation challenge) in both Veh- and TNFα-treated mice, which did not change 
significantly after either Veh or TNFα treatment (Fig. 6). However, 48 h after the TNFα 
treatment, the cough frequency during the NH3 inhalation challenge was elevated to more 
than five folds of that before the TNFα treatment, and the enhanced cough responsiveness to 
the NH3 inhalation challenge persisted even after 7 days (Fig. 6). In sharp contrast, there was 
no significant change in the cough response to NH3 at any of these time points after the Veh 
treatment.
The cough reflex elicited by NH3 of was probably elicited by activation of C-fibers and/or 
rapidly adapting receptors (RARs) located in the lung and airways [11,22,58] and/or tracheal 
cough receptors [40]. Indeed, using a single-fiber recording technique, we have shown that 
the NH3 (0.1% concentration) inhalation challenge stimulated both these two types of vagal 
bronchopulmonary afferents in anesthetized mice (unpublished data). However, we cannot 
evaluate the relative role(s) of these different afferents in the TNFα-induced increase in 
cough response to inhaled NH3 in this study.
NH3 has been shown to stimulate both TRPV1 and transient receptor potential ankyrine type 
1 (TRPA1) receptors [59]. Both TRPV1 and TRPA1 receptors are ligand-gated non-selective 
cation channels [34], and known to play important roles in the inflammation-induced 
hypersensitivity of vagal bronchopulmonary afferents [11,12]. Our earlier studies have 
demonstrated that he same TNFα treatment induced pronounced airway inflammation and 
elevated sensitivities of both C-fibers and RARs in the lungs. Together, these results seem to 
suggest that the increased cough responses to NH3 was caused by the TNFα-induced 
hypersensitivity of these bronchopulmonary afferents.
Conclusion
These studies demonstrated that intra-tracheal instillation of TNFα induced pronounced 
airway inflammation as illustrated by infiltration of eosinophils and neutrophils and the 
release of inflammatory mediators and cytokines in the lung and airways. Coinciding with 
the time of these changes, the TNFα treatment induced a distinct increase in the Cap 
sensitivity in vagal pulmonary C-fibers and silent RARs. Furthermore, the increased 
sensitivity to Cap was also present in the isolated pulmonary sensory neurons, suggesting 
that the sensitizing effect was mediated primarily through a direct action of TNFα on these 
neurons. Indeed, the same TNFα treatment also induced a lingering (> 7days) cough 
hyperresponsiveness to inhalation challenge of NH3 in awake mice, further illustrating the 
heightening sensitivity of these bronchopulmonary afferents.
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Stimulation of bronchopulmonary C-fiber afferents can also elicit bronchoconstriction and 
airway hypersecretion via the cholinergic reflex pathways [20,35]; intense stimulation can 
further generate neurogenic inflammation in the airways mediated through local axonal 
reflex mechanism [36,37]. Hence, when the excitability of C-fiber afferents is enhanced by 
endogenous TNFα, these airway reflex responses to a given stimulus is expected to be 
intensified. The finding of the TNFα-induced hypersensitivity of bronchopulmonary C-fiber 
afferents in these studies may explain, at least in part, the airway hyperresponsiveness and 
inflammation caused by Inhalation of TNFα in healthy humans [10].
Both the airway inflammation and the sensitizing effect on pulmonary sensory neurons 
caused by the TNFα treatment were abolished in the TNF−/− mice. These results further 
suggested the involvement of TNFR receptors. We believe that the activation of TNFRs by 
TNFα may activate several signaling pathways, trigger chemotactic actions, and enhance the 
release of inflammatory mediators and cytokines in the airways. Together, these TNFRs-
mediated actions may upregulate the sensitivity and/or expression of TRPV1 in the 
bronchopulmonary sensory nerves. Although the mechanism(s) underlying the potentiating 
effect of TNFα on these vagal bronchopulmonary sensory nerves is still not fully 
understood, these studies have established the evidence of this sensitizing effect of TNFα in 
mice, which should facilitate further investigations of the potential involvements of certain 
TNFR-mediated signaling pathways in transgenic and knockout mouse models.
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Fig. 1. 
Effect of TNFα treatment on inflammatory mediators in bronchoalveolar lavage fluid 
(BALF). Naïve group (open bars; WT mice receiving no surgery or treatment); Veh group 
(shaded bars; WT mice pretreated with vehicle PBS); TNFα group (closed bars; WT mice 
pretreated with TNFα); TNF−/− + TNFα group (hatched bars; TNF−/− mice pretreated with 
TNFα). BALF was collected at 24 hours after the pretreatment of TNFα or vehicle. LTB4 
and LTC4/D4/E4: leukotrienes B4 and C4/D4/E4, respectively; PTX3: pentraxin 3; PGE2: 
prostaglandin E2; TXB2, thromboxane B2; IL-13 and IL-1β: interleukins 13 and 1 beta, 
respectively. Each data point represents means ± SEM of the measurements; the total 
number of mice used in these groups varied: n = 10, 15, 15 and 5 in naïve, Veh, TNFα, and 
TNF−/− + TNFα groups, respectively. Thus, some tests (e.g., LTB4, IL-1β) were only 
performed in two or three groups of mice. *, significantly different from naïve group (P < 
0.05). #, significantly different from Veh group (P < 0.05). (Modified from reference [27])
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Fig. 2. 
A) Experimental records illustrating the effect of TNFα on the responses of pulmonary C 
fibers to capsaicin in anesthetized, open-chest and artificially ventilated mice. Vehicle (Veh; 
0.03 ml of PBS) and TNFα (10 µg/ml, 0.03 ml) were administered by intratracheal 
instillation into the lungs of Veh and TNFα mice (weights: 27.8 g & 25.9 g), respectively, ? 
24 h earlier. Arrows were added to mark the time when capsaicin (Cap; 1.0 µg/kg) was 
injected intravenously as a bolus. Both receptor locations were in the right lung. PT, tracheal 
pressure; AP, action potential; ABP, arterial blood pressure. B) Group data of pulmonary C 
fiber responses to the Cap injection ~24 h after the Veh (open bars) and TNFα (closed bars) 
treatments.. ΔFA: the increase in fiber activity (FA; impulses/s) from baseline (averaged over 
the 10-s period preceding the injection) to the peak response (averaged over 2-s duration) 
within the first 5 s after the injection. The number in each bar represents the number of 
fibers studied under that condition. * significantly different from the low dose of Cap (0.5 
µg/kg) (P < 0.05). # significantly different from the Veh group (P < 0.05). Data are means ± 
SEM. (Modified from reference [26])
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Fig. 3. 
A) & B): Experimental records illustrating the effect of TNFα on the responses of silent 
RARs to capsaicin, inflation and deflation of the lung in two anesthetized, open-chest and 
artificially ventilated mice. A) Veh (0.03 ml of PBS) and B) TNFα (10 µg/ml, 0.03 ml) were 
administered ~24 h earlier by intratracheal instillation into the lungs of Veh and TNFα mice 
(weights: 31.8 g & 25.9 g), respectively. In both A) and B), left panels: responses to constant 
pressure (30 cmH2O) hyperinflations of the lungs for 8 s when the ventilator was turned off; 
middle panels: responses to lung deflations when the expiratory line of the ventilator was 
exposed to atmospheric pressure; right panels: responses to intravenous bolus injections of 
capsaicin (1.0 µg/kg) at arrows. Both receptor locations were in the right lung. From C) to 
F): group data of silent RARs after treatments with Veh (open bars) and TNFα (closed 
bars). C): responses to Cap injections (0.5 & 1.0 µg/kg); see the legend of Fig. 2B for 
explanations. D): percentages of silent RARs that exhibited Cap sensitivity (ΔFA > 1.0 imp/s 
after Cap injection). E): response to lung hyperinflation (PT=30 cmH2O); ΔFA: the 
difference in FA between the first second of lung inflation and the baseline (averaged over 
10 s). F): response to lung deflation; ΔFA: the difference between the FA averaged over the 
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8-s duration of deflation and the baseline (averaged over 10 s). * significantly different from 
the Veh group (P < 0.05). (Modified from reference [26])
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Fig. 4. 
A) Representative experimental records illustrating the change in [Ca2+]i evoked by 
increasing concentrations of capsaicin in vagal pulmonary sensory neurons. Left panel: a 
pulmonary neuron (diameter: 24 µm) isolated from a wild-type (WT) mouse; Right panel: a 
pulmonary neuron (diameter: 22 µm) isolated from a TNF-receptor double homozygous 
mutant (TNF−/−) mouse. Both WT and TNF−/− neurons had been incubated with TNFα (50 
ng/ml in culture medium) for ~24 h. Cap was applied for 30 s each, and KCl solution (60 
mM, 20 s) was applied to test cell vitality at the end of each experiment. B) Group data 
showing a comparison of the responses of [Ca2+]i to increasing concentrations of Cap 
between Veh- and TNFα-treated neurons isolated from wild-type (WT) mice.. C) Group 
data illustrating the effect of TNFα treatment on the [Ca2+]i responses to increasing 
concentrations of Cap in neurons isolated from WT and TNF−/− mice. In both B) & C), *: 
significantly different from the corresponding response to 30 nM capsaicin (P < 0.05). # in 
B): significantly different from the corresponding data in Veh- treated neurons (P < 0.05); in 
C): significantly different from the corresponding data in TNF−/− neurons (P < 0.05). Data 
are mean ± SEM. (Modified from reference [26])
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Fig. 5. 
A): Schematic diagram of the experimental set-up. Mic: microphone for recording audio 
signal; Temp: air temperature in the chamber. B) Representative experimental records 
illustrating the characteristic features of pressure changes and the audio signal generated by 
a single cough (Left) and a single expiration reflex (Right) in an awake mouse. Pcham: 
pressure inside the chamber; Pip: intra-pleural pressure recorded via the telemetry sensor. 
(Modified from reference [28])
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Fig. 6. 
Effects of A) Vehicle (Veh, 0.03 ml of PBS; n=5) and B) TNFα (10 µg/ml, 0.03 ml; n=5) 
treatments on the cough response to inhalation challenge of NH3 (0.1%) in awake mice at 
different time points after the treatment. The cough frequency count included both cough 
and expiration reflex. Data (means ± SEM) represent the group responses averaged over the 
5-, 8- and 5-min durations of “Baseline”"During NH3” and “Recovery”, respectively. *, 
significantly (P < 0.05) different from the baseline data (open bars). #, significantly (P < 
0.05) different from the corresponding data obtained before the Veh or TNFα treatment.
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